Myc signaling, monocytes predict NSCLC response to second-line entinostat + pembroMay 2, 2019Lung CancerImmuno-oncology
ASCO: Deintensified treatment in p16+ oropharyngeal cancer needs evaluationMay 2, 2019Head & Neck/Thyroid Cancers
CBO’s report on single-payer health care holds more questions than answersMay 2, 2019Practice Management
CAR T-cell therapy bb2121 performs well in phase 1 trial of refractory multiple myelomaMay 1, 2019Lymphoma & Plasma Cell Disorders
Increase in pediatric thyroid cancers: overdiagnosis or something more?May 1, 2019Head & Neck/Thyroid CancersPediatrics
SRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung CancerImmuno-oncology
Conflicts of interest unreported in five of six oncology guidelines in JapanApril 30, 2019Practice Management
Vaginal brachytherapy more toxic than pelvic RT in endometrial carcinomaApril 30, 2019Gynecologic Cancer
High pCR rate in HPV+ HNSCC with nivolumab/SBRTApril 30, 2019Head & Neck/Thyroid CancersImmuno-oncology
MYSTIC trial: bTMB correlates with tTMB, predicts survival in mNSCLCApril 30, 2019Lung CancerImmuno-oncology
Head and neck cancer cost analysis yields simple bundled payment modelApril 29, 2019Head & Neck/Thyroid CancersPractice Management
